AAAAAA

   
Results: 1-9 |
Results: 9
Low-molecular-weight heparin administration in patients with end-stage renal disease - Author's reply
Authors: Brophy, DF Wazny, LD Gehr, TWB Comstock, TJ Venitz, J
Citation: Df. Brophy et al., Low-molecular-weight heparin administration in patients with end-stage renal disease - Author's reply, PHARMACOTHE, 21(8), 2001, pp. 1017-1019
The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease
Authors: Brophy, DF Wazny, LD Gehr, TWB Comstock, TJ Venitz, J
Citation: Df. Brophy et al., The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease, PHARMACOTHE, 21(2), 2001, pp. 169-174
Pharmacokinetic interaction between amprenavir and rifabutin or rifampin in healthy males
Authors: Polk, RE Brophy, DF Israel, DS Patron, R Sadler, BM Chittick, GE Symonds, WT Lou, Y Kristoff, D Stein, DS
Citation: Re. Polk et al., Pharmacokinetic interaction between amprenavir and rifabutin or rifampin in healthy males, ANTIM AG CH, 45(2), 2001, pp. 502-508
Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia
Authors: Wazny, LD Brophy, DF
Citation: Ld. Wazny et Df. Brophy, Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia, ANN PHARMAC, 34(1), 2000, pp. 94-97
Cost-effectiveness of sevelamer versus calcium carbonate plus atorvastatinto reduce LDL in patients with chronic renal insufficiency with dyslipidemia and hyperphosphatemia
Authors: Brophy, DF Wallace, JF Kennedy, DT Gehr, TWB Holdford, DA
Citation: Df. Brophy et al., Cost-effectiveness of sevelamer versus calcium carbonate plus atorvastatinto reduce LDL in patients with chronic renal insufficiency with dyslipidemia and hyperphosphatemia, PHARMACOTHE, 20(8), 2000, pp. 952-959
The pharmacokinetics and pharmacodynamics of losartan in continuous ambulatory peritoneal dialysis
Authors: Pedro, AA Gehr, TWB Brophy, DF Sica, DA
Citation: Aa. Pedro et al., The pharmacokinetics and pharmacodynamics of losartan in continuous ambulatory peritoneal dialysis, J CLIN PHAR, 40(4), 2000, pp. 389-395
Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers
Authors: Brophy, DF Israel, DS Pastor, A Gillotin, C Chittick, GE Symonds, WT Lou, Y Sadler, BM Polk, RE
Citation: Df. Brophy et al., Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers, ANTIM AG CH, 44(4), 2000, pp. 978-984
Pharmacotherapy of dyslipidemia in postmenopausal women: Weighing the evidence
Authors: Brophy, DF Crouch, MA Ruffin, DM Wazny, LD McKenney, JM
Citation: Df. Brophy et al., Pharmacotherapy of dyslipidemia in postmenopausal women: Weighing the evidence, J WOMEN H G, 8(7), 1999, pp. 901-917
Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysis
Authors: Brophy, DF Sowinski, KM Kraus, MA Moe, SM Klaunig, JE Mueller, BA
Citation: Df. Brophy et al., Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysis, PERIT DIA I, 19(6), 1999, pp. 534-539
Risultati: 1-9 |